Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,392 Jan 1 – Oct 24, 2026
- Disclosed funding
- $206B 2016 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| KS Provides AI-managed cloud for FedRAMP authorization | $25M | Series A | AI, Cybersecurity | United States | Investors | |
| S SequenCompany profile Delivers real-time AI ranking and personalization infrastructure for enterprise consumer companies Delivers real-time AI ranking and personalization infrastructure for enterprise consumer companies | $16M | Series A | AI, Enterprise software | United States | Investors | |
| VR Builds industrial-grade AI engine for video generation | $30M | StrategicUndisclosed | AI | Singapore | Investors | |
| G GridBeyondCompany profile Provides intelligent energy technology and optimisation of distributed energy assets Provides intelligent energy technology and optimisation of distributed energy assets | €12M | Growth | AI, Climate tech | Ireland | Investors | |
| S SequentialCompany profile Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis Develops non-invasive multi-omic testing platform for skin health and cosmetics using AI and microbiome analysis | $3.5M | Seed | AI, Healthtech | United States | Investors | |
| A AlomanaCompany profile An enterprise AI platform for building and running workflows across business data, applications and communication channels. An enterprise AI platform for building and running workflows across business data, applications and communication channels. | €4M | Seed | AI | Italy | Investors | |
| ST Surf TherapeuticsCompany profile Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases | $6M | Seed | AI, Healthtech | United States | Investors | |
| L LaminarCompany profile Open-source observability platform for tracing and debugging long-running AI agents Open-source observability platform for tracing and debugging long-running AI agents | $3M | Seed | AI | United States | Investors | |
| C Provides in-app communication platform with conversational AI agents | $6.5M | StrategicUndisclosed | AI, Enterprise software | United States | Investors | |
| LH Builds an upstream security platform for enterprises | $6M | Pre-SeedPre-seed | AI, Cybersecurity | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Greptile, Nous Research
108rounds2led - 2General Catalyst
Tractian, Legora, Different
79rounds6led - 3Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
79rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
67rounds7led - 5Accel
Legora, Arda Industries
55rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.